Gallant Dm
Impact in
- Psychiatry and Mental health top 5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Epilepsy research and treatment
- Electroconvulsive Therapy Studies
Papers in
-
- Schizophrenia research and treatment 18
- Electroconvulsive Therapy Studies 6
- Epilepsy research and treatment 5
- Bipolar Disorder and Treatment 3
-
- Mental Health and Psychiatry 9
- Co-authors
- R Guerrero-Figueroa (14 shared papers)Christof Kessler (2 shared papers)George Rb (1 shared paper)Phillips Jh (1 shared paper)Hugh Collins (1 shared paper)Roger Downer (1 shared paper)Peter V. Rabins (1 shared paper)W.N. Shelton (1 shared paper)
- Journals
- PubMed (56 papers)
- Partner nations
- United States
In The Last Decade
Gallant Dm
54 papers receiving 345 citations
Peers
Comparison fields: 5 of 72
- Psychiatry and Mental health 248
- Biological Psychiatry 16
- Clinical Psychology 88
- Cellular and Molecular Neuroscience 60
- Pharmacology 53
Countries citing papers authored by Gallant Dm
This map shows the geographic impact of Gallant Dm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gallant Dm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gallant Dm more than expected).
Fields of papers citing papers by Gallant Dm
This network shows the impact of papers produced by Gallant Dm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gallant Dm. The network helps show where Gallant Dm may publish in the future.
Co-authors
The 8 scholars most cited alongside Gallant Dm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients. | 1976 | 98 |
| 2 | Group psychotherapy with married couples: a successful technique in New Orleans alcoholism clinic patients. | 1970 | 33 |
| 3 | Sulpiride: evaluation of antipsychotic activity in schizophrenic patients. | 1977 | 18 |
| 4 | Thiothixene (P-4657B): a controlled evaluation in chronic schizophrenic patients. | 1966 | 16 |
| 5 | Thiothixene versus trifluoperazine in newly-admitted schizophrenic patients. | 1966 | 16 |
| 6 | COMPARISON OF HALOPERIDOL, TRIFLUPERIDOL, AND CHLORPROMAZINE IN ACUTE SCHIZOPHRENIC PATIENTS. | 1964 | 15 |
| 7 | A six-month controlled evaluation of metronidazole (Flagyl) in chronic alcoholic patients. | 1968 | 13 |
| 8 | CL-67,772: a preliminary evaluation of a potential antidepressant compound. Animal and human correlations. | 1969 | 13 |
| 9 | A CONTROLLED EVALUATION OF TRIFLUPERIDOL: A NEW POTENT PSYCHOPHARMACOLOGIC AGENT. | 1963 | 12 |
| 10 | A CONTROLLED EVALUATION OF BUTAPERAZINE IN CHRONIC SCHIZOPHRENIC PATIENTS. | 1964 | 10 |
| 11 | DPN (NAD-oxidized form): a preliminary evaluation in chronic schizophrenic patients. | 1966 | 10 |
| 12 | Butaclamol hydrochloride (AY-23,028): an early evaluation in severely ill schizophrenics. | 1975 | 10 |
| 13 | Cinanserin (SQ. 10,643): a preliminary evaluation in chronic schizophrenic patients. | 1968 | 9 |
| 14 | Amoxapine: a double-blind evaluation of antidepressant activity. | 1973 | 8 |
| 15 | U-28,774 (ketozolam): an early evaluation of a new antianxiety agent. | 1973 | 7 |
| 16 | Electrocardiographic evaluation of mesoridazine (Serentil). | 1972 | 7 |
| 17 | Extended trial of thiothixene in chronic psychotic patients. | 1968 | 6 |
| 18 | Electrocardiographic evaluation of thiothixene: a double-blind comparison with thioridazine. | 1974 | 6 |
| 19 | Molindone: a crossover evaluation of capsule and tablet formulations in severely ill schizophrenic patients. | 1973 | 6 |
| 20 | Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action. | 1967 | 6 |
About Gallant Dm
Gallant Dm is a scholar working on Psychiatry and Mental health, Philosophy, Pharmacology, Organic Chemistry and Molecular Biology, having authored 56 papers that have together received 419 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (18 papers), Mental Health and Psychiatry (9 papers), Treatment of Major Depression (7 papers), Electroconvulsive Therapy Studies (6 papers), Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (3 papers), Bipolar Disorder and Treatment (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). The work is most often cited by research in Psychiatry and Mental health (248 citations), Biological Psychiatry (16 citations), Clinical Psychology (88 citations), Cellular and Molecular Neuroscience (60 citations) and Pharmacology (53 citations). Gallant Dm has collaborated with scholars based in United States. Frequent co-authors include R Guerrero-Figueroa, Christof Kessler, George Rb, Phillips Jh, Hugh Collins, Roger Downer, Peter V. Rabins and W.N. Shelton. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.